8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Linfocitos T-CAR en pacientes con mieloma múltiple Translated title: CAR T-cells in patients with multiple myeloma

      editorial
      ,
      Farmacia Hospitalaria
      Grupo Aula Médica

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: not found
          • Article: not found

          Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Multiple Myeloma

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

              Belantamab mafodotin (GSK2857916), an immunoconjugate targeting B-cell maturation antigen, showed single-agent activity in the phase 1 DREAMM-1 study in heavily pre-treated patients with relapsed or refractory multiple myeloma. We further investigated the safety and activity of belantamab mafodotin in the DREAMM-2 study.
                Bookmark

                Author and article information

                Journal
                fh
                Farmacia Hospitalaria
                Farm Hosp.
                Grupo Aula Médica (Toledo, Toledo, Spain )
                1130-6343
                2171-8695
                October 2021
                : 45
                : 5
                : 219-220
                Affiliations
                [1] Salamanca orgnameHospital Universitario de Salamanca orgdiv1Instituto de Investigación Biomédica de Salamanca España
                [2] Salamanca Castilla y León orgnameUniversidad de Salamanca orgdiv1Instituto de Biología Molecular y Celular del Cáncer Spain
                Article
                S1130-63432021000500001 S1130-6343(21)04500500001
                10.7399/fh.11800
                574190e5-362f-44a8-8fda-fdfbb28969da

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                : 26 July 2021
                : 19 July 2021
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 9, Pages: 2
                Product

                SciELO Spain

                Categories
                Editoriales

                Comments

                Comment on this article